Hann-Chorng Kuo1, Shu-Hsin Liu. 1. Department of Urology, Buddhist Tzu Chi General Hospital and Tzu Chi University, Hualien, Taiwan. hck@tzuchi.com.tw
Abstract
AIMS: To investigate the therapeutic effects of repeated detrusor onabotulinumtoxinA injections on urinary incontinence and renal function in patients with chronic spinal cord injuries (SCI). METHODS: Patients with suprasacral SCI were enrolled. OnabotulinumtoxinA 200 U detrusor injections were repeated every 6 months for four times. Patients were instructed to perform clean intermittent catheterization during the treatment and follow-up periods. Videourodynamic study and 99mTc-DTPA renal scanning for glomerular filtration rate (GFR) were performed at screening and every 3 months to assess the therapeutic effects on bladder and renal function. Quality of life was measured by the UDI-6, IIQ-7, and self-assessed QoL indices. Adverse events were also recorded. RESULTS: A total of 33 patients completed the study, 30 had improvement in incontinence grade (n = 18) or became completely dry (n = 12) after initial and subsequent onabotulinumtoxinA injections. Mean bladder capacity increased from 207 ± 111 to 412 ± 33 ml and mean detrusor pressure decreased from 39.8 ± 21.7 to 20.6 ± 19.1 cmH(2) O (all P < 0.05). However, the mean GFR decreased from 93.4 ± 20.4 to 83.5 ± 24 ml/min (P = 0.028). A significant reduction in GFR was noted in patients with bladder compliance that increased by <10 cmH(2) O (P = 0.002) and in patients with Pdet decreased by <10 cmH(2) O after treatment (P = 0.036). All 30 patients with improvement in incontinence grade satisfied with treatment result. CONCLUSION: This pilot study revealed that repeated detrusor injections of 200 U onabotulinumtoxinA could reduce incontinence grade, increase bladder capacity, and decrease intravesical pressure but this study did not demonstrate an improvement in GFR over a 24-month period in patients with chronic SCI.
AIMS: To investigate the therapeutic effects of repeated detrusor onabotulinumtoxinA injections on urinary incontinence and renal function in patients with chronic spinal cord injuries (SCI). METHODS:Patients with suprasacral SCI were enrolled. OnabotulinumtoxinA 200 U detrusor injections were repeated every 6 months for four times. Patients were instructed to perform clean intermittent catheterization during the treatment and follow-up periods. Videourodynamic study and 99mTc-DTPA renal scanning for glomerular filtration rate (GFR) were performed at screening and every 3 months to assess the therapeutic effects on bladder and renal function. Quality of life was measured by the UDI-6, IIQ-7, and self-assessed QoL indices. Adverse events were also recorded. RESULTS: A total of 33 patients completed the study, 30 had improvement in incontinence grade (n = 18) or became completely dry (n = 12) after initial and subsequent onabotulinumtoxinA injections. Mean bladder capacity increased from 207 ± 111 to 412 ± 33 ml and mean detrusor pressure decreased from 39.8 ± 21.7 to 20.6 ± 19.1 cmH(2) O (all P < 0.05). However, the mean GFR decreased from 93.4 ± 20.4 to 83.5 ± 24 ml/min (P = 0.028). A significant reduction in GFR was noted in patients with bladder compliance that increased by <10 cmH(2) O (P = 0.002) and in patients with Pdet decreased by <10 cmH(2) O after treatment (P = 0.036). All 30 patients with improvement in incontinence grade satisfied with treatment result. CONCLUSION: This pilot study revealed that repeated detrusor injections of 200 U onabotulinumtoxinA could reduce incontinence grade, increase bladder capacity, and decrease intravesical pressure but this study did not demonstrate an improvement in GFR over a 24-month period in patients with chronic SCI.
Authors: Subramanian Vaidyanathan; Fahed Selmi; Kottarathil Abraham Abraham; Peter Hughes; Gurpreet Singh; Bakul Soni Journal: Patient Saf Surg Date: 2012-09-26